Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period ...
“Consistently high blood sugar levels can signal metabolic conditions like diabetes, prediabetes or insulin ... Continuous glucose monitor (CGM): A CGM is a device that measures your blood ...
Last year, it launched Stelo in the U.S., an over-the-counter CGM option that can be used by pre-diabetes patients. This initiative significantly increased the company's target market since in the ...
In a real-world analysis, the cost of CGM use during a type 1 diabetes pregnancy was less than self-monitoring blood glucose. The cost savings were tied to a lower rate of neonatal ICU admissions ...
BEIRUT, Feb 5 (Reuters) - Syria's General Authority for Land and Sea Ports said on Wednesday that it had agreed to a new contract with French shipping and logistics group CMA CGM to operate the ...
(MENAFN- GlobeNewsWire - Nasdaq) Trinity Biotech's patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029 DUBLIN, Feb. 06, 2025 (GLOBE ...
The latest analysis confirms that first-day accuracy – a critical performance metric for CGM users – shows an approximately 35% improvement in Mean Absolute Relative Difference and a more than ...
Trinity Biotech (TRIB) announced results from its latest pre-pivotal clinical trial for its next-generation continuous glucose monitoring system. “We believe that our patented technology ...
The latest analysis confirms that first-day accuracy - a critical performance metric for CGM users - shows an approximately 35% improvement in Mean Absolute Relative Difference (MARD) and a more than ...
“People who have pre-diabetes may be really interested in using this because they’re trying to prevent the development of diabetes,” Surampudi said. It’s not uncommon for diabetes to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results